Browsing Tag
NSE: ADVENZYMES
1 post
Advanced Enzyme Technologies reports flat FY25 earnings as human nutrition slows, international sales drive growth
Advanced Enzymes reports 2% revenue growth for FY25 amid margin pressure. Find out how global sales, probiotics, and B2C bets shape its future.